HMA drafts strategy to improve EU medicines network
This article was originally published in SRA
Executive Summary
The European Heads of Medicines Agencies has developed a draft strategy to identify and deal with key challenges facing the European medicines network in the future. While the strategy covers diverse activities, the focus is on issues that can make a "real difference" to the European Union medicines network over the next five years1.